{"id":141352,"date":"2014-09-12T13:55:01","date_gmt":"2014-09-12T17:55:01","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/feds-give-cellerant-47-5m-for-stem-cell-treatment-that-preps-for-nuclear-disaster.php"},"modified":"2014-09-12T13:55:01","modified_gmt":"2014-09-12T17:55:01","slug":"feds-give-cellerant-47-5m-for-stem-cell-treatment-that-preps-for-nuclear-disaster","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/stem-cell-therapy\/feds-give-cellerant-47-5m-for-stem-cell-treatment-that-preps-for-nuclear-disaster.php","title":{"rendered":"Feds give Cellerant $47.5M for stem cell treatment that preps for nuclear disaster"},"content":{"rendered":"<p><p>    Stem cell therapy    is one way thegovernments preparing for a    nationimpacted by nuclear disaster.  <\/p>\n<p>    Cellerant Therapeutics    has received $47.5 million from the government to develop its    treatment for radiation poisoning. If approved, the feds could    buy the drug for the Strategic    National Stockpile, which is a part of     Project Bioshield- a portion of the Bush-era War on    Terror that medically readies the nation against    chemical, biological, radiological or nuclear    attacks.  <\/p>\n<p>    This is part of a $163.8 million commitment from    theBiomedical Advanced Research and Development    Authority, or BARDA.  <\/p>\n<p>    The new dollars will go toward San Carlos, California-based    Cellerants Phase 2 trial in patients with acute myeloid    leukemia, as well as the preclinical trials to treat radiation    poisoning, or Acute Radiation Syndrome.  <\/p>\n<p>    As it relates toradiation    poisoning, Cellerant said its drugCLT-008 is meant to    provide hematopoietic support after exposure to ionizing    radiation such as from a nuclear or radiological weapon, or    from a nuclear accident, it said in a statement.  <\/p>\n<p>    The privately held    company also recently wrapped up early-stage clinical    studies in patients with acute myeloid leukemia, as well as in    patients that are undergoing an umbilical cord blood    transplant. Cellerant found CLT-008, was safely tolerated in 75    patients, it said in a statement. Its Phase 2 is testing for a    decrease in risk of     febrile neutropenia, and infections stemming from chemo.  <\/p>\n<p>    CLT-008 is essentially a collection of deep-freezed stem cells    that can ultimately defrost and mature into working    granulocytes, platelets and red blood cells in a person. In    nonclinical models, Cellerant has shown that the treatments    highly effective in providing protection from lethal    radiation, preventing infection, facilitating stem cell    engraftment and improving overall survival.  <\/p>\n<\/p>\n<p>              Get our daily newsletter or follow us.            <\/p>\n<p>                Please enter your email below:              <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>View post: <\/p>\n<p><a target=\"_blank\" href=\"http:\/\/medcitynews.com\/2014\/09\/feds-give-cellerant-47-5m-stem-cell-treatment-preps-nuclear-disaster\" title=\"Feds give Cellerant $47.5M for stem cell treatment that preps for nuclear disaster\">Feds give Cellerant $47.5M for stem cell treatment that preps for nuclear disaster<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Stem cell therapy is one way thegovernments preparing for a nationimpacted by nuclear disaster.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/stem-cell-therapy\/feds-give-cellerant-47-5m-for-stem-cell-treatment-that-preps-for-nuclear-disaster.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[25],"tags":[],"class_list":["post-141352","post","type-post","status-publish","format-standard","hentry","category-stem-cell-therapy"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/141352"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=141352"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/141352\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=141352"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=141352"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=141352"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}